Cary, N.C. – September 19, 2011 – Industry Standard Research (ISR) today announced the release of an important piece of research, this one profiling the post-marketing safety industry. ISR’s new “Post-marketing Safety Market Overview and Outlook” report provides pharmaceutical companies and service providers with much-needed data on the underserved post-marketing safety marketplace.   Compiled from research with 68 pharma and biotech executives responsible for post-marketing activities, ISR’s comprehensive report provides the industry with a view into outsourcing conditions, growth and decline in study volume, and their attitudes toward outsourcing these critical responsibilities.   “The data tell us that sponsors are ready and eager to outsource some components of post-marketing safety and more hesitant for others. This means selecting the right partner for outsourcing is more important – and more difficult – for these activities than for most others. These data arm sponsors with everything they need to be confident throughout that important process,” explained Kevin Olson, CEO of Industry Standard Research and a 13-year industry veteran. Olson continued by adding that service providers will also benefit from this deep dive research as they enter their 2012 strategic planning process.”It’s difficult getting insight into the growth figures of any industry, but this one is especially challenging and we know service providers will see a lot of benefit.”   ISR’s new report also profiles leadership perceptions, performance, usage, and loyalty of many different large and mid-size CROs and specialty safety providers and gives a service-by-service look at the criteria sponsors use to select their service providers.   “This market has received very little market research attention,” explained Olson. “With our newest release, ISR has now captured and profiled service provider performance across Phase I, Phase II/III clinical trials, Clinical Technologies, and now Post-marketing safety.”   Specific post-marketing safety services profiled in this report include: Phase IV non-interventional studies, REMS programs, Signal Detection and Reporting, EU QPPV (Qualified Person for Pharmacovigilance in the European Union), and Scientific Literature Searches.   About Industry Standard Research Industry Standard Research is the premier, full-service market research provider to the pharma and pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@isrreports.com, or follow us on Twitter @ISRreports.

ISR CUSTOMERS